Approaches and challenges for the manufacture and scale-out of autologous cell therapies

In by

Spotlight Article

Interview

Richard P Harrison

Strategies for Scale-up & Scale-out

 

Dr Richard Harrison is an EPSRC ETERM Fellow at Loughborough University. His research is primarily focused on the manufacturing of advanced therapies, more specifically the future manufacturing paradigms these advanced therapies will require. As these advanced healthcare products do not fit easily into existing manufacturing solutions, Richard’s research examines the business models, distribution networks, cost of goods and reimbursement strategies that may suit these therapies, and cost of goods modeling. A particular focus of this strategy is investigating the feasibility of decentralized manufacturing of advanced therapies across diverse geographical regions. Richard holds a BSc in Biochemistry, an MSc in Stem Cell Technologies and a PhD in targeting of cell therapies. He was awarded his E-TERM Landscape Fellowship in 2016 and is currently based at Loughborough University with Visiting Fellow status at The University of Nottingham.

DOI: 10.18609/cgti.2017.076
Citation: Cell Gene Therapy Insights 2017; 3(9), 749-753.
Open access

This content is restricted to registered users. Click here to Register or Login here.